{"hands_on_practices": [{"introduction": "When a laboratory adopts a new measurement method, it must rigorously verify that its performance meets clinical requirements. This fundamental practice [@problem_id:5236018] guides you through the calculation of Total Error ($TE$), a key performance metric that combines systematic error (bias) and random error (imprecision) into a single value. By comparing the observed total error ($TE_{obs}$) to the allowable total error ($TE_a$), you can make an objective, evidence-based decision on whether a method is fit for its intended use.", "problem": "A clinical chemistry laboratory operating under the International Organization for Standardization (ISO) 15189 and Clinical Laboratory Improvement Amendments (CLIA) quality requirements is verifying a new total cholesterol method at the medical decision level. The assigned value from a reference measurement procedure at the decision level is $C^{\\*} = 200$ mg/dL. To characterize systematic and random components of error, the laboratory measures a single patient pool (commutable material) in $n = 10$ replicate runs under routine conditions, obtaining the following results in mg/dL: $201$, $202$, $203$, $200$, $205$, $199$, $204$, $202$, $201$, $203$.\n\nUsing the fundamental definitions that systematic error (bias) is the difference between the method’s average result and the assigned value, that imprecision is quantified by the sample standard deviation of replicate results, and that a two-sided $95\\%$ Gaussian coverage factor corresponds to a multiplier of $1.96$ on the standard deviation, derive from first principles an expression for the observed total error at $95\\%$ coverage and compute it. The allowable total error for total cholesterol at this level is defined by the Clinical Laboratory Improvement Amendments (CLIA) target as a fraction of the assigned value, specifically $TE_{a} = 0.10 \\times C^{\\*}$ mg/dL.\n\nDefine the fitness margin as $M = TE_{a} - TE_{obs}$ in mg/dL, where a positive $M$ indicates the method is fit for the intended clinical use at the decision level and a negative $M$ indicates it is not fit. Report the single quantity $M$ in mg/dL, rounded to three significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n-   Assigned value from a reference measurement procedure: $C^{\\*} = 200$ mg/dL.\n-   Number of replicate runs: $n = 10$.\n-   Replicate results ($x_i$) in mg/dL: $201$, $202$, $203$, $200$, $205$, $199$, $204$, $202$, $201$, $203$.\n-   Definition of systematic error (bias): The difference between the method’s average result ($\\bar{x}$) and the assigned value ($C^{\\*}$), i.e., $\\text{Bias} = \\bar{x} - C^{\\*}$.\n-   Definition of imprecision: Quantified by the sample standard deviation ($s$) of replicate results.\n-   Coverage factor: A two-sided $95\\%$ Gaussian coverage factor corresponds to a multiplier of $Z = 1.96$.\n-   Definition of observed total error ($TE_{obs}$): To be derived from the combination of bias and imprecision at $95\\%$ coverage.\n-   Definition of allowable total error ($TE_{a}$): $TE_{a} = 0.10 \\times C^{\\*}$.\n-   Definition of fitness margin ($M$): $M = TE_{a} - TE_{obs}$.\n-   Required output: The value of $M$, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded in the principles of metrology and statistics as applied to clinical laboratory method validation. The concepts of bias, imprecision, total error, and allowable error are standard in this field (e.g., under CLIA and ISO $15189$ guidelines). The provided data and definitions are sufficient, consistent, and do not violate any physical or logical principles. The problem is well-posed, objective, and a unique, meaningful solution can be determined.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\n### Derivation and Calculation\nThe first step is to derive the expression for the observed total error, $TE_{obs}$, from the principles provided. Total error is the combined effect of systematic error (bias) and random error (imprecision). A common model for total error, which is consistent with the problem's use of a coverage factor, is the linear sum of the absolute bias and a multiple of the standard deviation representing the random error component at a specified confidence level.\n\nThe expression for observed total error at $95\\%$ coverage is therefore:\n$$TE_{obs} = |\\text{Bias}| + Z_{95\\%} \\times s$$\nwhere $|\\text{Bias}|$ is the absolute value of the systematic error, $s$ is the imprecision (sample standard deviation), and $Z_{95\\%}$ is the Gaussian coverage factor for $95\\%$ confidence.\n\nTo compute $TE_{obs}$, we must first calculate the sample mean ($\\bar{x}$) and sample standard deviation ($s$) from the provided data.\n\nThe sample mean, $\\bar{x}$, is calculated as:\n$$\\bar{x} = \\frac{1}{n} \\sum_{i=1}^{n} x_i$$\nUsing the given $n=10$ replicate results:\n$$\\sum_{i=1}^{10} x_i = 201 + 202 + 203 + 200 + 205 + 199 + 204 + 202 + 201 + 203 = 2020$$\n$$\\bar{x} = \\frac{2020}{10} = 202 \\text{ mg/dL}$$\n\nNext, we calculate the systematic error (Bias). As defined, this is the difference between the sample mean and the assigned reference value, $C^{\\*}$.\n$$\\text{Bias} = \\bar{x} - C^{\\*} = 202 \\text{ mg/dL} - 200 \\text{ mg/dL} = 2 \\text{ mg/dL}$$\nThe absolute value of the bias is $|\\text{Bias}| = |2| = 2$ mg/dL.\n\nNext, we calculate the imprecision, which is quantified by the sample standard deviation, $s$. The formula for the sample standard deviation is:\n$$s = \\sqrt{\\frac{1}{n-1} \\sum_{i=1}^{n} (x_i - \\bar{x})^2}$$\nThe sum of squared deviations from the mean, $\\sum (x_i - \\bar{x})^2$, is:\n$$ (201 - 202)^2 + (202 - 202)^2 + (203 - 202)^2 + (200 - 202)^2 + (205 - 202)^2 + (199 - 202)^2 + (204 - 202)^2 + (202 - 202)^2 + (201 - 202)^2 + (203 - 202)^2 $$\n$$ = (-1)^2 + (0)^2 + (1)^2 + (-2)^2 + (3)^2 + (-3)^2 + (2)^2 + (0)^2 + (-1)^2 + (1)^2 $$\n$$ = 1 + 0 + 1 + 4 + 9 + 9 + 4 + 0 + 1 + 1 = 30 $$\nWith $n=10$, the sample variance, $s^2$, is:\n$$s^2 = \\frac{30}{10-1} = \\frac{30}{9} = \\frac{10}{3}$$\nThe sample standard deviation, $s$, is:\n$$s = \\sqrt{\\frac{10}{3}} \\text{ mg/dL}$$\n\nNow we can compute the observed total error, $TE_{obs}$, using the given coverage factor $Z_{95\\%} = 1.96$:\n$$TE_{obs} = |\\text{Bias}| + 1.96 \\times s = 2 + 1.96 \\times \\sqrt{\\frac{10}{3}}$$\n$$TE_{obs} \\approx 2 + 1.96 \\times 1.82574 = 2 + 3.57845 \\approx 5.57845 \\text{ mg/dL}$$\n\nThe next step is to calculate the allowable total error, $TE_{a}$, based on the CLIA goal for total cholesterol:\n$$TE_{a} = 0.10 \\times C^{\\*} = 0.10 \\times 200 \\text{ mg/dL} = 20 \\text{ mg/dL}$$\n\nFinally, we compute the fitness margin, $M$, which is defined as the difference between the allowable total error and the observed total error:\n$$M = TE_{a} - TE_{obs}$$\n$$M = 20 - \\left( 2 + 1.96 \\sqrt{\\frac{10}{3}} \\right) \\approx 20 - 5.57845 = 14.42155 \\text{ mg/dL}$$\n\nThe problem requires the final answer for $M$ to be rounded to three significant figures.\n$$M \\approx 14.4 \\text{ mg/dL}$$\nSince the value of $M$ is positive ($14.4 > 0$), the method is considered fit for its intended clinical use at this decision level.", "answer": "$$\\boxed{14.4}$$", "id": "5236018"}, {"introduction": "Beyond initial validation, a mature Quality Management System requires continuous monitoring of process capability. The sigma metric is a powerful concept adapted from industrial engineering that provides a universal score for process quality. This exercise [@problem_id:5154893] challenges you to calculate a method's sigma value, which quantifies how many standard deviations of process variation fit within the allowable error margins, providing a clear benchmark of performance and guiding quality control strategy.", "problem": "A high-throughput molecular diagnostics laboratory accredited under International Organization for Standardization 15189 (ISO 15189) and subject to Clinical Laboratory Improvement Amendments (CLIA) plans to justify a risk-based quality control (QC) strategy for a quantitative Polymerase Chain Reaction (PCR) viral load assay. The Laboratory Information System (LIS) aggregates method performance data and produces the following compliance-relevant summary metrics, each expressed as a percentage of the assay’s target value: Total Allowable Error (TEa) $=15\\%$ (adopted from an accepted regulatory/consensus source), method bias $=3\\%$ (signed, representing systematic error relative to the target), and within-laboratory standard deviation (SD) $=2\\%$ (imprecision estimated from internal QC over a suitable period).\n\nUsing fundamental definitions from analytical quality management in laboratory medicine, proceed as follows: starting from the concept that method capability is quantified by how many units of imprecision fit between the method mean and the applicable specification limit, and that systematic error displaces the method mean from the target while imprecision widens results about that mean, derive the expression for the process capability index in standard deviation units (the sigma metric) in terms of TEa, the magnitude of bias, and SD. Then, compute its numerical value using the LIS-provided TEa, bias, and SD above. Express the final sigma metric as a pure number (unitless) and round your answer to three significant figures.\n\nNote: In your reasoning, treat bias as a signed quantity but use its magnitude when determining the remaining margin to the allowable error limit. Do not assume any specific QC rule set a priori; instead, base your derivation on core definitions (allowable error, bias, and imprecision) as they relate to capability in units of standard deviation. Your final answer must be only the computed sigma metric.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n- Total Allowable Error ($TE_a$): $15\\%$ of the target value.\n- Method bias ($B$): $3\\%$ of the target value (signed).\n- Within-laboratory standard deviation ($SD$): $2\\%$ of the target value (imprecision).\n- Task 1: Derive the expression for the process capability index (sigma metric, $\\sigma_{metric}$) in terms of $TE_a$, the magnitude of bias $|B|$, and $SD$.\n- Task 2: Compute the numerical value of the sigma metric.\n- Task 3: Express the final answer as a pure number, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem uses standard, well-defined concepts from analytical quality management in clinical laboratories, including Total Allowable Error ($TE_a$), bias ($B$), and imprecision ($SD$). The sigma metric is a widely accepted measure of process capability derived from Six Sigma principles and adapted for laboratory medicine. The context of ISO 15189 and CLIA regulations is appropriate and realistic. The provided numerical values are plausible for a quantitative molecular assay.\n- **Well-Posed**: The problem is clearly stated. It provides all necessary data and a conceptual framework for deriving the required formula. A unique, meaningful solution exists.\n- **Objective**: The problem is expressed in precise, quantitative, and unbiased language. It is based on established metrological definitions.\n- **Completeness and Consistency**: The problem is self-contained and internally consistent. It provides all data needed for the calculation.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically sound, well-posed, and objective. A solution will be derived.\n\n### Derivation and Solution\n\nThe sigma metric ($\\sigma_{metric}$) quantifies the capability of a measurement process by relating its performance (bias and imprecision) to the quality requirements (total allowable error). The fundamental concept, as stated in the problem, is to determine how many units of process imprecision (standard deviations) fit into the allowable margin for error.\n\nLet the target value for the analyte be $T$.\nThe Total Allowable Error, $TE_a$, defines the boundaries of acceptable performance. The specification limits are the Upper Specification Limit ($USL$) and the Lower Specification Limit ($LSL$).\nThe $USL$ is the highest acceptable value, defined as:\n$$USL = T + TE_a$$\nThe $LSL$ is the lowest acceptable value, defined as:\n$$LSL = T - TE_a$$\nThe total tolerance interval has a width of $2 \\times TE_a$.\n\nBias, $B$, represents the systematic error, which is the difference between the mean of the measurement process, $\\mu$, and the true target value, $T$.\n$$\\mu = T + B$$\nA non-zero bias shifts the entire distribution of results away from the target value.\n\nImprecision, or random error, is quantified by the within-laboratory standard deviation, $SD$. This describes the spread of the results around the process mean, $\\mu$.\n\nThe capability of the process is limited by the distance from the process mean, $\\mu$, to the nearest specification limit. This distance represents the remaining analytical \"room\" or margin available for random error ($SD$) before an unacceptable result is produced.\n\nLet's calculate the distance from the process mean $\\mu$ to each specification limit:\nDistance to $USL = USL - \\mu = (T + TE_a) - (T + B) = TE_a - B$\nDistance to $LSL = \\mu - LSL = (T + B) - (T - TE_a) = TE_a + B$\n\nThe \"worst-case\" scenario corresponds to the smaller of these two distances, which is the margin on the side to which the bias has shifted the mean. This shortest distance is determined by the magnitude of the bias, $|B|$.\nIf $B > 0$, the mean is shifted towards the $USL$, and the shortest distance is $TE_a - B = TE_a - |B|$.\nIf $B  0$, the mean is shifted towards the $LSL$, and the shortest distance is $TE_a + B = TE_a - (-B) = TE_a - |B|$.\nTherefore, the general expression for the distance from the mean to the nearest specification limit is $TE_a - |B|$.\n\nThe sigma metric is defined as the number of standard deviations ($SD$) that can fit within this shortest distance.\nThus, the derived expression for the sigma metric is:\n$$\\sigma_{metric} = \\frac{TE_a - |B|}{SD}$$\n\nNow, we compute the numerical value using the provided data. The quantities $TE_a$, $B$, and $SD$ are all expressed as percentages of the target value. Since the sigma metric is a ratio, the units (in this case, `%` of target value) cancel out, yielding a dimensionless number.\n\nGiven:\n$TE_a = 15\\% = 0.15$\n$B = 3\\% = 0.03$, so its magnitude is $|B| = 0.03$\n$SD = 2\\% = 0.02$\n\nSubstituting these values into the derived formula:\n$$\\sigma_{metric} = \\frac{0.15 - 0.03}{0.02}$$\n$$\\sigma_{metric} = \\frac{0.12}{0.02}$$\n$$\\sigma_{metric} = 6$$\n\nThe problem requires the answer to be rounded to three significant figures. The integer $6$ must be expressed with two additional decimal places to reflect this precision.\n$$\\sigma_{metric} = 6.00$$\nThis value indicates that the process is operating at a \"Six Sigma\" level of quality, which is considered world-class performance. It means that the distance from the process mean to the nearest specification limit is equal to six times the process standard deviation.", "answer": "$$\\boxed{6.00}$$", "id": "5154893"}, {"introduction": "A comprehensive QMS addresses risks across the entire workflow, not just in the analytical phase. Failure Modes and Effects Analysis (FMEA) is a structured, proactive technique used to identify and mitigate potential failures before they occur. In this practice [@problem_id:5236047], you will apply FMEA to the critical pre-analytical step of specimen labeling, learning to quantify risk with Risk Priority Numbers ($RPN$) and use a risk-benefit analysis to select the most effective process improvements.", "problem": "A clinical laboratory accredited under International Organization for Standardization $15189$ is strengthening its quality management system for the pre-analytical phase. As part of risk management, the laboratory conducts a Failure Modes and Effects Analysis (FMEA) to evaluate specimen labeling. In FMEA, each failure mode is rated for severity $S$, occurrence $O$, and detection $D$ on a scale from $1$ (best) to $10$ (worst), with higher $S$ indicating more severe patient impact, higher $O$ indicating more frequent occurrence, and higher $D$ indicating lower detectability by existing controls. Using the standard FMEA approach, compute the Risk Priority Number (RPN) for each failure mode, then use these results to inform mitigation selection.\n\nBaseline failure modes and ratings determined by a multidisciplinary team are:\n$1.$ Illegible handwriting on labels: $S=4$, $O=6$, $D=5$.\n$2.$ Wrong patient identifier on label: $S=9$, $O=3$, $D=6$.\n$3.$ Missing collection time on label: $S=5$, $O=7$, $D=4$.\n$4.$ Label detaches during transport: $S=7$, $O=2$, $D=8$.\n$5.$ Duplicate tubes labeled for the same patient but with mismatched tests: $S=8$, $O=4$, $D=7$.\n\nFive candidate mitigations, each with an implementation burden score (workflow and resource impact, higher values indicate greater burden), and expected rating changes are proposed:\n$M_1$: Electronic order entry with print-on-demand barcode labels. Effects: for failure mode $1$, $O:6\\rightarrow 2$; for failure mode $3$, $O:7\\rightarrow 5$; for failure mode $5$, $D:7\\rightarrow 5$. Burden score $=14$.\n$M_2$: Bedside barcode scanning for patient identification at phlebotomy. Effects: for failure mode $2$, $O:3\\rightarrow 1$, $D:6\\rightarrow 3$; for failure mode $5$, $O:4\\rightarrow 2$. Burden score $=18$.\n$M_3$: Cryo-resistant, high-adhesive labels with secondary affixation. Effects: for failure mode $4$, $O:2\\rightarrow 1$, $D:8\\rightarrow 5$. Burden score $=8$.\n$M_4$: Mandatory time-stamp capture enforced via handheld device workflow. Effects: for failure mode $3$, $O:7\\rightarrow 4$, $D:4\\rightarrow 2$. Burden score $=10$.\n$M_5$: Double-check station with secondary verification before batching. Effects: for failure mode $5$, $D:7\\rightarrow 4$; for failure mode $1$, $D:5\\rightarrow 3$. Burden score $=12$.\n\nAssume severity $S$ does not change with these mitigations. Define the risk-benefit ratio for a mitigation as the total $RPN$ reduction achieved across all affected failure modes per unit of implementation burden. Select the single mitigation that maximizes this ratio. After implementing only that mitigation, compute the aggregate residual $RPN$ summed across all five failure modes.\n\nRound your final numeric answer to three significant figures. Express your answer without units.", "solution": "The problem is evaluated to be scientifically grounded, well-posed, objective, and self-contained. The methodology described, Failure Modes and Effects Analysis (FMEA), is a standard risk management technique, and its application in a clinical laboratory setting under ISO $15189$ is appropriate. The data provided are complete and consistent for solving the problem as stated. Therefore, the problem is valid and a solution can be derived.\n\nThe core of the analysis is the Risk Priority Number ($RPN$), which, according to the standard FMEA approach, is the product of the ratings for Severity ($S$), Occurrence ($O$), and Detection ($D$).\n$$RPN = S \\times O \\times D$$\nThe problem requires us to first calculate the baseline RPNs, then evaluate a series of potential mitigations based on a defined risk-benefit ratio, select the optimal mitigation, and finally calculate the aggregate residual RPN after its implementation.\n\nFirst, we calculate the baseline RPN for each of the five failure modes ($F_1$ to $F_5$).\n\nFor $F_1$ (Illegible handwriting): $S_1=4$, $O_1=6$, $D_1=5$\n$$RPN_{1, \\text{base}} = 4 \\times 6 \\times 5 = 120$$\n\nFor $F_2$ (Wrong patient identifier): $S_2=9$, $O_2=3$, $D_2=6$\n$$RPN_{2, \\text{base}} = 9 \\times 3 \\times 6 = 162$$\n\nFor $F_3$ (Missing collection time): $S_3=5$, $O_3=7$, $D_3=4$\n$$RPN_{3, \\text{base}} = 5 \\times 7 \\times 4 = 140$$\n\nFor $F_4$ (Label detaches): $S_4=7$, $O_4=2$, $D_4=8$\n$$RPN_{4, \\text{base}} = 7 \\times 2 \\times 8 = 112$$\n\nFor $F_5$ (Duplicate tubes, mismatched tests): $S_5=8$, $O_5=4$, $D_5=7$\n$$RPN_{5, \\text{base}} = 8 \\times 4 \\times 7 = 224$$\n\nThe total baseline aggregate RPN is the sum of these individual values:\n$$RPN_{\\text{total, base}} = 120 + 162 + 140 + 112 + 224 = 758$$\n\nNext, we evaluate each mitigation ($M_1$ to $M_5$). The risk-benefit ratio ($RBR$) is defined as the total RPN reduction ($\\Delta RPN_{\\text{total}}$) per unit of implementation burden ($B$).\n$$RBR = \\frac{\\Delta RPN_{\\text{total}}}{B}$$\n\nFor each mitigation, we calculate the new RPN for the affected failure modes and the resulting RPN reduction, $\\Delta RPN = RPN_{\\text{base}} - RPN_{\\text{new}}$.\n\nMitigation $M_1$ (Burden $B_1=14$):\n- $F_1$: $O_1$ changes $6 \\rightarrow 2$. $RPN_{1, \\text{new}} = S_1 \\times O_{1, \\text{new}} \\times D_1 = 4 \\times 2 \\times 5 = 40$. $\\Delta RPN_1 = 120 - 40 = 80$.\n- $F_3$: $O_3$ changes $7 \\rightarrow 5$. $RPN_{3, \\text{new}} = S_3 \\times O_{3, \\text{new}} \\times D_3 = 5 \\times 5 \\times 4 = 100$. $\\Delta RPN_3 = 140 - 100 = 40$.\n- $F_5$: $D_5$ changes $7 \\rightarrow 5$. $RPN_{5, \\text{new}} = S_5 \\times O_5 \\times D_{5, \\text{new}} = 8 \\times 4 \\times 5 = 160$. $\\Delta RPN_5 = 224 - 160 = 64$.\n- $\\Delta RPN_{\\text{total}, 1} = 80 + 40 + 64 = 184$.\n- $RBR_1 = \\frac{184}{14} \\approx 13.143$.\n\nMitigation $M_2$ (Burden $B_2=18$):\n- $F_2$: $O_2$ changes $3 \\rightarrow 1$, $D_2$ changes $6 \\rightarrow 3$. $RPN_{2, \\text{new}} = S_2 \\times O_{2, \\text{new}} \\times D_{2, \\text{new}} = 9 \\times 1 \\times 3 = 27$. $\\Delta RPN_2 = 162 - 27 = 135$.\n- $F_5$: $O_5$ changes $4 \\rightarrow 2$. $RPN_{5, \\text{new}} = S_5 \\times O_{5, \\text{new}} \\times D_5 = 8 \\times 2 \\times 7 = 112$. $\\Delta RPN_5 = 224 - 112 = 112$.\n- $\\Delta RPN_{\\text{total}, 2} = 135 + 112 = 247$.\n- $RBR_2 = \\frac{247}{18} \\approx 13.722$.\n\nMitigation $M_3$ (Burden $B_3=8$):\n- $F_4$: $O_4$ changes $2 \\rightarrow 1$, $D_4$ changes $8 \\rightarrow 5$. $RPN_{4, \\text{new}} = S_4 \\times O_{4, \\text{new}} \\times D_{4, \\text{new}} = 7 \\times 1 \\times 5 = 35$. $\\Delta RPN_4 = 112 - 35 = 77$.\n- $\\Delta RPN_{\\text{total}, 3} = 77$.\n- $RBR_3 = \\frac{77}{8} = 9.625$.\n\nMitigation $M_4$ (Burden $B_4=10$):\n- $F_3$: $O_3$ changes $7 \\rightarrow 4$, $D_3$ changes $4 \\rightarrow 2$. $RPN_{3, \\text{new}} = S_3 \\times O_{3, \\text{new}} \\times D_{3, \\text{new}} = 5 \\times 4 \\times 2 = 40$. $\\Delta RPN_3 = 140 - 40 = 100$.\n- $\\Delta RPN_{\\text{total}, 4} = 100$.\n- $RBR_4 = \\frac{100}{10} = 10$.\n\nMitigation $M_5$ (Burden $B_5=12$):\n- $F_5$: $D_5$ changes $7 \\rightarrow 4$. $RPN_{5, \\text{new}} = S_5 \\times O_5 \\times D_{5, \\text{new}} = 8 \\times 4 \\times 4 = 128$. $\\Delta RPN_5 = 224 - 128 = 96$.\n- $F_1$: $D_1$ changes $5 \\rightarrow 3$. $RPN_{1, \\text{new}} = S_1 \\times O_1 \\times D_{1, \\text{new}} = 4 \\times 6 \\times 3 = 72$. $\\Delta RPN_1 = 120 - 72 = 48$.\n- $\\Delta RPN_{\\text{total}, 5} = 96 + 48 = 144$.\n- $RBR_5 = \\frac{144}{12} = 12$.\n\nComparing the risk-benefit ratios:\n- $RBR_1 \\approx 13.143$\n- $RBR_2 \\approx 13.722$\n- $RBR_3 = 9.625$\n- $RBR_4 = 10.0$\n- $RBR_5 = 12.0$\n\nThe maximum RBR corresponds to mitigation $M_2$. Thus, $M_2$ is selected for implementation.\n\nThe final step is to compute the aggregate residual RPN after implementing only mitigation $M_2$. This is the total baseline RPN minus the total RPN reduction achieved by $M_2$.\n$$RPN_{\\text{residual}} = RPN_{\\text{total, base}} - \\Delta RPN_{\\text{total}, 2}$$\n$$RPN_{\\text{residual}} = 758 - 247 = 511$$\n\nAlternatively, we can sum the new RPNs after $M_2$ is implemented. The RPNs for $F_1$, $F_3$, and $F_4$ are unchanged from baseline. The RPNs for $F_2$ and $F_5$ are updated.\n- $RPN_{1, \\text{new}} = 120$\n- $RPN_{2, \\text{new}} = 27$\n- $RPN_{3, \\text{new}} = 140$\n- $RPN_{4, \\text{new}} = 112$\n- $RPN_{5, \\text{new}} = 112$\nAggregate residual RPN $= 120 + 27 + 140 + 112 + 112 = 511$.\n\nThe result, $511$, has three significant figures, so no further rounding is needed.", "answer": "$$\\boxed{511}$$", "id": "5236047"}]}